9-69174357-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBS2_Supporting
The NM_004817.4(TJP2):c.-16G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000596 in 1,551,550 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 5 hom. )
Consequence
TJP2
NM_004817.4 5_prime_UTR_premature_start_codon_gain
NM_004817.4 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0550
Genes affected
TJP2 (HGNC:11828): (tight junction protein 2) This gene encodes a zonula occluden that is a member of the membrane-associated guanylate kinase homolog family. The encoded protein functions as a component of the tight junction barrier in epithelial and endothelial cells and is necessary for proper assembly of tight junctions. Mutations in this gene have been identified in patients with hypercholanemia, and genomic duplication of a 270 kb region including this gene causes autosomal dominant deafness-51. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 9-69174357-G-T is Benign according to our data. Variant chr9-69174357-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 259548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TJP2 | ENST00000377245 | c.-16G>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 23 | 1 | NM_004817.4 | ENSP00000366453.4 | |||
TJP2 | ENST00000377245 | c.-16G>T | 5_prime_UTR_variant | Exon 1 of 23 | 1 | NM_004817.4 | ENSP00000366453.4 | |||
ENSG00000285130 | ENST00000642889.1 | c.447+22586G>T | intron_variant | Intron 3 of 24 | ENSP00000493780.1 |
Frequencies
GnomAD3 genomes AF: 0.00285 AC: 434AN: 152218Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
434
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000750 AC: 117AN: 155930 AF XY: 0.000499 show subpopulations
GnomAD2 exomes
AF:
AC:
117
AN:
155930
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000349 AC: 489AN: 1399214Hom.: 5 Cov.: 35 AF XY: 0.000303 AC XY: 209AN XY: 690188 show subpopulations
GnomAD4 exome
AF:
AC:
489
AN:
1399214
Hom.:
Cov.:
35
AF XY:
AC XY:
209
AN XY:
690188
Gnomad4 AFR exome
AF:
AC:
403
AN:
31646
Gnomad4 AMR exome
AF:
AC:
20
AN:
35724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25166
Gnomad4 EAS exome
AF:
AC:
0
AN:
35770
Gnomad4 SAS exome
AF:
AC:
1
AN:
79254
Gnomad4 FIN exome
AF:
AC:
0
AN:
49150
Gnomad4 NFE exome
AF:
AC:
11
AN:
1078944
Gnomad4 Remaining exome
AF:
AC:
52
AN:
57980
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00286 AC: 435AN: 152336Hom.: 2 Cov.: 33 AF XY: 0.00295 AC XY: 220AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
435
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
220
AN XY:
74486
Gnomad4 AFR
AF:
AC:
0.00986051
AN:
0.00986051
Gnomad4 AMR
AF:
AC:
0.00137219
AN:
0.00137219
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000293971
AN:
0.0000293971
Gnomad4 OTH
AF:
AC:
0.00094518
AN:
0.00094518
Heterozygous variant carriers
0
24
48
71
95
119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jul 17, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at